Interestingly, higher proportion of mutation for both TP53 and BAP1 was observed in T-eff group compared to Angio group, and PBRM1 mutation with Angio compared to T-eff group of ccRCC patients (Supplementary Table ST3). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.